Mobile respiratory clinics have emerged as an innovative solution to improve access to healthcare services for populations in remote, underserved, or high-risk areas. These clinics provide on-site screening, diagnosis, and management of various respiratory conditions, including asthma, chronic obstructive pulmonary disease, and other pulmonary disorders, without requiring patients to travel long distances to medical centers. Mobile respiratory clinics emphasize early detection and preventive care, offering lung function testing, vaccinations, health education, and personalized counseling to help individuals manage their conditions effectively. By bringing healthcare directly to the community, these clinics reduce barriers related to transportation, socioeconomic constraints, and limited healthcare infrastructure. They also facilitate ongoing monitoring and follow-up care, using portable diagnostic tools and electronic health records to maintain continuity of care. Multidisciplinary teams, including pulmonologists, respiratory therapists, nurses, and community health workers, collaborate to deliver comprehensive services that address both clinical and educational needs. Mobile respiratory clinics also play a critical role during public health emergencies, such as air pollution episodes or infectious respiratory outbreaks, by providing rapid assessment and guidance. Evidence indicates that these outreach models improve patient engagement, adherence to treatment plans, and overall respiratory health outcomes, while reducing hospital admissions and healthcare costs. By integrating flexibility, accessibility, and preventive strategies, mobile respiratory clinics enhance community-level lung health and ensure that quality respiratory care reaches those who need it most, fostering long-term wellness across diverse populations.
Title : Screening questionnaires for obstructive sleep apnea: An updated systematic review
Behzad Rahmati, Isfahan University of Medical Sciences, Iran (Islamic Republic of)
Title : Improving covid 19 candidate vaccine response through probiotics and micronutrient supplementation: Evaluating the role of TLR5
Zohre Eftekhari, Biotechnology Research Center, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Novel signaling mechanisms and innovative therapeutic strategies of pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Iatrogenic pneumothorax following nephrectomy: Case report
Chaimae Tahiri, National University Hospital Center of Fann, Senegal